MDT•benzinga•
Medtronic Presented Late-Breaking Data Showing Performance Of Its OmniaSecure Defibrillation Lead Met Its Primary Safety And Effectiveness Endpoints, Exceeding Prespecified Performance Goals, In The Global LEADR Pivotal Trial
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 17, 2024 by benzinga